About | Free Trial

Last Update

2015-06-18T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Timothy Crowder?

Dr. Timothy Crowder Timm

Vice President of Technical Operations

Spyryx Biosciences

Spyryx Biosciences

Background Information

Employment History

Director of Advanced Manufacturing Technology At the GSK Manufacturing Facility
GlaxoSmithKline plc

Vice President
Oriel Therapeutics Inc.

Affiliations

Board Member
Oriel Therapeutics Inc.

Education

Ph.D.

UNC

degrees
physics
Davidson College

degrees
physics
North Carolina State University

Web References (12 Total References)


Research Triangle Park, N.C. -- Timothy ...

ltw.m0bl.net [cached]

Research Triangle Park, N.C. -- Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.

Crowder joined Spyryx from GlaxoSmithKline, where he was most recently director of advanced manufacturing technology at the GSK manufacturing facility in Zebulon.
In his new role reporting to Spyryx president and CEO John Taylor, Crowder is responsible for inhalation delivery technologies for the company's pulmonary therapeutics, and for overseeing manufacturing and supply chain strategies for them.
...
Before Crowder joined GSK, he was a co-founder of Oriel Therapeutics, a Durham-based inhaler technology company built around device designs he developed during his graduate research. He earned his Ph.D. from UNC and has degrees in physics from North Carolina State University and Davidson College.


Timothy "Timm" Crowder, Ph.D. -- Spyryx ...

www.ncbiotech.org [cached]

Timothy "Timm" Crowder, Ph.D. -- Spyryx photo

Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.
Crowder joined Spyryx from GlaxoSmithKline, where he was most recently director of advanced manufacturing technology at the GSK manufacturing facility in Zebulon.
In his new role reporting to Spyryx president and CEO John Taylor, Crowder is responsible for inhalation delivery technologies for the company's pulmonary therapeutics, and for overseeing manufacturing and supply chain strategies for them.
...
Before Crowder joined GSK, he was a co-founder of Oriel Therapeutics, a Durham-based inhaler technology company built around device designs he developed during his graduate research. He earned his Ph.D. from UNC and has degrees in physics from North Carolina State University and Davidson College.


Oriel Therapeutics: Leadership

www.orieltherapeutics.com [cached]

Timothy M. Crowder, PhD - Vice President, Powder Technology

...
Timothy M. Crowder, PhD - VP, Oriel Therapeutics, Inc.
...
Timothy M. Crowder, PhD - Vice President, Powder Technology and FounderTimm's dissertation research, concerning the physics of powder flow and its application to dispersion in dry powder inhalers, forms the basis for Oriel's technology platform.His research at UNC included the direction of an industrially-sponsored nasal dry powder vaccine project and developing a prototype dry powder inhaler and dispersion mechanism.Dr. Crowder completed his Ph.D. in the Department of Biomedical Engineering at the University of North Carolina, Chapel Hill under the supervision of Professor Anthony Hickey.


NCBiotech News | North Carolina Biotech Center

www.ncbiotech.org [cached]

Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.


Dr. Timothy Crowder, of Oriel ...

triangle.triangle.dbusinessnews.com [cached]

Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference

...
Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference
...
Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference
Triangle -
Durham - Dr. Timothy Crowder of Oriel Therapeutics will be presenting recent research findings at the Particulate Processes in the Pharmaceutical Industry Conference.
...
Crowder is a founder of Oriel Therapeutics.He completed his Ph.D. in the Department of Biomedical Engineering at the University of North Carolina, Chapel Hill.His dissertation research, concerning the physics of powder flow and its application to dispersion in dry powder inhalers, forms the basis for Oriel's technology platform.His research at UNC included the direction of an industrially-sponsored nasal dry powder vaccine project and developing a prototype dry powder inhaler and dispersion mechanism.

Similar Profiles

Other People with this Name

Other people with the name Crowder

Matthew Crowder
Acumen I.T. LLC

Keri Crowder
UAMS

Mitch Crowder
Marvel Architects PLLC

Bonnie Crowder
D'Andrea Visual Communications

Sharon Crowder
IU Simon Cancer Center

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory